August 28, 2019—CBSET announced that its scientists have published data and analyses that provide critical insights into the interplay between target anatomy and device attributes in determining balloon- and stent-based paclitaxel retention in healthy and diseased arteries. According to CBSET, these findings may transform the understanding of the safety and efficacy of paclitaxel-coated devices used in the treatment of peripheral artery disease.
The article, “Taking Paclitaxel Coated Balloons to a Higher Level: Predicting Coating Dissolution Kinetics, Tissue Retention and Dosing Dynamics,” by Abraham R. Tzafriri, PhD; Sahil A. Parikh, MD; and Elazer R. Edelman, MD, is available in Journal of Controlled Release (2019;310:94–102).